Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes
2013 · Diagnostic Pathology · 71 citations
https://doi.org/10.1186/1746-1596-8-129
P
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
139
Papers
3.8K
Citations
34
h-index
76
i10-index
Peng Su is an academic researcher from North China University of Science and Technology. The author has contributed to research in topics: Hippo pathway signaling and YAP/TAZ & Ubiquitin and proteasome pathways & Economic Sanctions and International Relations. The author has an h-index of 34, co-authored 119 publications.
ORCID: 0000-0002-7000-0474Papers by this author
worksImmunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue
2010 · Diagnostic Pathology · 56 citations
https://doi.org/10.1186/1746-1596-5-38
ABCG2 is associated with HER-2 Expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma
2011 · Diagnostic Pathology · 45 citations
https://doi.org/10.1186/1746-1596-6-90
Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma
2012 · Diagnostic Pathology · 44 citations
https://doi.org/10.1186/1746-1596-7-32
DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
2022 · Journal of Experimental & Clinical Cancer Research · 34 citations
https://doi.org/10.1186/s13046-022-02410-5
PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα
2023 · Oncogene · 30 citations
https://doi.org/10.1038/s41388-023-02905-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat